nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—TOP2A—Epirubicin—uterine cancer	0.152	0.217	CbGbCtD
Levofloxacin—SLC22A2—Progesterone—uterine cancer	0.133	0.189	CbGbCtD
Levofloxacin—TOP2A—Etoposide—uterine cancer	0.119	0.169	CbGbCtD
Levofloxacin—TOP2A—Doxorubicin—uterine cancer	0.0809	0.115	CbGbCtD
Levofloxacin—CYP1A2—Progesterone—uterine cancer	0.0405	0.0577	CbGbCtD
Levofloxacin—ABCB1—Progesterone—uterine cancer	0.0354	0.0504	CbGbCtD
Levofloxacin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.032	0.0456	CbGbCtD
Levofloxacin—ABCB1—Dactinomycin—uterine cancer	0.0281	0.04	CbGbCtD
Levofloxacin—CYP3A4—Progesterone—uterine cancer	0.0212	0.0302	CbGbCtD
Levofloxacin—CYP1A2—Etoposide—uterine cancer	0.0181	0.0258	CbGbCtD
Levofloxacin—ABCB1—Etoposide—uterine cancer	0.0159	0.0226	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—uterine cancer	0.0108	0.0154	CbGbCtD
Levofloxacin—CYP3A4—Etoposide—uterine cancer	0.0095	0.0135	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—uterine cancer	0.00648	0.00922	CbGbCtD
Levofloxacin—TOP2A—myometrium—uterine cancer	0.00166	0.0757	CbGeAlD
Levofloxacin—SLC22A4—myometrium—uterine cancer	0.00133	0.0605	CbGeAlD
Levofloxacin—SLC22A2—renal system—uterine cancer	0.0013	0.0594	CbGeAlD
Levofloxacin—TOP2A—uterine cervix—uterine cancer	0.00129	0.0589	CbGeAlD
Levofloxacin—TOP2A—decidua—uterine cancer	0.00123	0.0561	CbGeAlD
Levofloxacin—TOP2A—endometrium—uterine cancer	0.00117	0.0532	CbGeAlD
Levofloxacin—TOP2A—mammalian vulva—uterine cancer	0.00113	0.0515	CbGeAlD
Levofloxacin—TOP2A—uterus—uterine cancer	0.00108	0.0491	CbGeAlD
Levofloxacin—SLC22A4—decidua—uterine cancer	0.000984	0.0449	CbGeAlD
Levofloxacin—SLC22A4—renal system—uterine cancer	0.000966	0.0441	CbGeAlD
Levofloxacin—SLC22A4—endometrium—uterine cancer	0.000934	0.0426	CbGeAlD
Levofloxacin—TOP2A—female gonad—uterine cancer	0.00088	0.0401	CbGeAlD
Levofloxacin—TOP2A—vagina—uterine cancer	0.000874	0.0399	CbGeAlD
Levofloxacin—SLC22A4—female reproductive system—uterine cancer	0.000774	0.0353	CbGeAlD
Levofloxacin—SLC22A4—vagina—uterine cancer	0.0007	0.0319	CbGeAlD
Levofloxacin—TOP2A—Teniposide—Etoposide—uterine cancer	0.000646	0.136	CbGdCrCtD
Levofloxacin—TOP2A—Podofilox—Etoposide—uterine cancer	0.000646	0.136	CbGdCrCtD
Levofloxacin—CYP1A2—renal system—uterine cancer	0.000579	0.0264	CbGeAlD
Levofloxacin—TOP2A—lymph node—uterine cancer	0.000566	0.0258	CbGeAlD
Levofloxacin—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.000527	0.111	CbGdCrCtD
Levofloxacin—TOP2A—Methyltestosterone—Progesterone—uterine cancer	0.000459	0.0965	CbGdCrCtD
Levofloxacin—SLC22A4—lymph node—uterine cancer	0.000453	0.0206	CbGeAlD
Levofloxacin—CYP3A4—renal system—uterine cancer	0.000419	0.0191	CbGeAlD
Levofloxacin—ABCB1—myometrium—uterine cancer	0.000408	0.0186	CbGeAlD
Levofloxacin—TOP2A—Daunorubicin—Epirubicin—uterine cancer	0.000337	0.0707	CbGdCrCtD
Levofloxacin—TOP2A—Doxorubicin—Epirubicin—uterine cancer	0.000337	0.0707	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Epirubicin—uterine cancer	0.000337	0.0707	CbGdCrCtD
Levofloxacin—CYP3A4—female reproductive system—uterine cancer	0.000336	0.0153	CbGeAlD
Levofloxacin—ABCB1—epithelium—uterine cancer	0.00032	0.0146	CbGeAlD
Levofloxacin—ABCB1—uterine cervix—uterine cancer	0.000317	0.0145	CbGeAlD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—uterine cancer	0.000312	0.0655	CbGdCrCtD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—uterine cancer	0.000312	0.0655	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	0.000312	0.0655	CbGdCrCtD
Levofloxacin—ABCB1—decidua—uterine cancer	0.000302	0.0138	CbGeAlD
Levofloxacin—TOP2A—Norethindrone—Progesterone—uterine cancer	0.000299	0.0629	CbGdCrCtD
Levofloxacin—ABCB1—renal system—uterine cancer	0.000297	0.0135	CbGeAlD
Levofloxacin—ABCB1—endometrium—uterine cancer	0.000287	0.0131	CbGeAlD
Levofloxacin—ABCB1—mammalian vulva—uterine cancer	0.000277	0.0127	CbGeAlD
Levofloxacin—ABCB1—uterus—uterine cancer	0.000264	0.0121	CbGeAlD
Levofloxacin—TOP2A—Levonorgestrel—Progesterone—uterine cancer	0.000238	0.05	CbGdCrCtD
Levofloxacin—ABCB1—female reproductive system—uterine cancer	0.000238	0.0108	CbGeAlD
Levofloxacin—ABCB1—female gonad—uterine cancer	0.000216	0.00987	CbGeAlD
Levofloxacin—ABCB1—vagina—uterine cancer	0.000215	0.00981	CbGeAlD
Levofloxacin—ABCB1—lymph node—uterine cancer	0.000139	0.00634	CbGeAlD
Levofloxacin—Pollakiuria—Epirubicin—uterine cancer	9.56e-05	0.000353	CcSEcCtD
Levofloxacin—Eosinophilia—Doxorubicin—uterine cancer	9.48e-05	0.00035	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Epirubicin—uterine cancer	9.44e-05	0.000349	CcSEcCtD
Levofloxacin—Paraesthesia—Etoposide—uterine cancer	9.42e-05	0.000348	CcSEcCtD
Levofloxacin—Pancreatitis—Doxorubicin—uterine cancer	9.38e-05	0.000347	CcSEcCtD
Levofloxacin—Weight decreased—Epirubicin—uterine cancer	9.36e-05	0.000346	CcSEcCtD
Levofloxacin—Dyspnoea—Etoposide—uterine cancer	9.36e-05	0.000346	CcSEcCtD
Levofloxacin—Hyperglycaemia—Epirubicin—uterine cancer	9.33e-05	0.000345	CcSEcCtD
Levofloxacin—Somnolence—Etoposide—uterine cancer	9.33e-05	0.000345	CcSEcCtD
Levofloxacin—Angina pectoris—Doxorubicin—uterine cancer	9.32e-05	0.000345	CcSEcCtD
Levofloxacin—Pneumonia—Epirubicin—uterine cancer	9.28e-05	0.000343	CcSEcCtD
Levofloxacin—Infestation NOS—Epirubicin—uterine cancer	9.22e-05	0.000341	CcSEcCtD
Levofloxacin—Infestation—Epirubicin—uterine cancer	9.22e-05	0.000341	CcSEcCtD
Levofloxacin—Drowsiness—Epirubicin—uterine cancer	9.22e-05	0.000341	CcSEcCtD
Levofloxacin—Vomiting—Dactinomycin—uterine cancer	9.22e-05	0.000341	CcSEcCtD
Levofloxacin—Bronchitis—Doxorubicin—uterine cancer	9.21e-05	0.00034	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	9.14e-05	0.000338	CcSEcCtD
Levofloxacin—Rash—Dactinomycin—uterine cancer	9.14e-05	0.000338	CcSEcCtD
Levofloxacin—Decreased appetite—Etoposide—uterine cancer	9.12e-05	0.000337	CcSEcCtD
Levofloxacin—Pancytopenia—Doxorubicin—uterine cancer	9.09e-05	0.000336	CcSEcCtD
Levofloxacin—Renal failure—Epirubicin—uterine cancer	9.07e-05	0.000335	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Etoposide—uterine cancer	9.06e-05	0.000335	CcSEcCtD
Levofloxacin—Fatigue—Etoposide—uterine cancer	9.05e-05	0.000334	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Epirubicin—uterine cancer	9.04e-05	0.000334	CcSEcCtD
Levofloxacin—Stomatitis—Epirubicin—uterine cancer	8.99e-05	0.000332	CcSEcCtD
Levofloxacin—Jaundice—Epirubicin—uterine cancer	8.99e-05	0.000332	CcSEcCtD
Levofloxacin—Constipation—Etoposide—uterine cancer	8.97e-05	0.000332	CcSEcCtD
Levofloxacin—Pain—Etoposide—uterine cancer	8.97e-05	0.000332	CcSEcCtD
Levofloxacin—Conjunctivitis—Epirubicin—uterine cancer	8.97e-05	0.000331	CcSEcCtD
Levofloxacin—Dysuria—Doxorubicin—uterine cancer	8.95e-05	0.000331	CcSEcCtD
Levofloxacin—Neutropenia—Doxorubicin—uterine cancer	8.95e-05	0.000331	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Doxorubicin—uterine cancer	8.9e-05	0.000329	CcSEcCtD
Levofloxacin—Pollakiuria—Doxorubicin—uterine cancer	8.84e-05	0.000327	CcSEcCtD
Levofloxacin—Haematuria—Epirubicin—uterine cancer	8.79e-05	0.000325	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Doxorubicin—uterine cancer	8.74e-05	0.000323	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Epirubicin—uterine cancer	8.72e-05	0.000322	CcSEcCtD
Levofloxacin—Epistaxis—Epirubicin—uterine cancer	8.7e-05	0.000322	CcSEcCtD
Levofloxacin—Weight decreased—Doxorubicin—uterine cancer	8.66e-05	0.00032	CcSEcCtD
Levofloxacin—Sinusitis—Epirubicin—uterine cancer	8.65e-05	0.00032	CcSEcCtD
Levofloxacin—Feeling abnormal—Etoposide—uterine cancer	8.65e-05	0.00032	CcSEcCtD
Levofloxacin—Hyperglycaemia—Doxorubicin—uterine cancer	8.63e-05	0.000319	CcSEcCtD
Levofloxacin—Nausea—Dactinomycin—uterine cancer	8.61e-05	0.000318	CcSEcCtD
Levofloxacin—Agranulocytosis—Epirubicin—uterine cancer	8.61e-05	0.000318	CcSEcCtD
Levofloxacin—Pneumonia—Doxorubicin—uterine cancer	8.58e-05	0.000317	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Etoposide—uterine cancer	8.58e-05	0.000317	CcSEcCtD
Levofloxacin—Infestation NOS—Doxorubicin—uterine cancer	8.53e-05	0.000315	CcSEcCtD
Levofloxacin—Infestation—Doxorubicin—uterine cancer	8.53e-05	0.000315	CcSEcCtD
Levofloxacin—Drowsiness—Doxorubicin—uterine cancer	8.53e-05	0.000315	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	8.46e-05	0.000313	CcSEcCtD
Levofloxacin—Bradycardia—Epirubicin—uterine cancer	8.43e-05	0.000312	CcSEcCtD
Levofloxacin—Renal failure—Doxorubicin—uterine cancer	8.39e-05	0.00031	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Doxorubicin—uterine cancer	8.37e-05	0.000309	CcSEcCtD
Levofloxacin—Urticaria—Etoposide—uterine cancer	8.34e-05	0.000308	CcSEcCtD
Levofloxacin—Haemoglobin—Epirubicin—uterine cancer	8.32e-05	0.000308	CcSEcCtD
Levofloxacin—Stomatitis—Doxorubicin—uterine cancer	8.32e-05	0.000307	CcSEcCtD
Levofloxacin—Jaundice—Doxorubicin—uterine cancer	8.32e-05	0.000307	CcSEcCtD
Levofloxacin—Rhinitis—Epirubicin—uterine cancer	8.3e-05	0.000307	CcSEcCtD
Levofloxacin—Abdominal pain—Etoposide—uterine cancer	8.3e-05	0.000307	CcSEcCtD
Levofloxacin—Body temperature increased—Etoposide—uterine cancer	8.3e-05	0.000307	CcSEcCtD
Levofloxacin—Conjunctivitis—Doxorubicin—uterine cancer	8.3e-05	0.000307	CcSEcCtD
Levofloxacin—Haemorrhage—Epirubicin—uterine cancer	8.28e-05	0.000306	CcSEcCtD
Levofloxacin—Hepatitis—Epirubicin—uterine cancer	8.28e-05	0.000306	CcSEcCtD
Levofloxacin—Hypoaesthesia—Epirubicin—uterine cancer	8.24e-05	0.000304	CcSEcCtD
Levofloxacin—Pharyngitis—Epirubicin—uterine cancer	8.22e-05	0.000304	CcSEcCtD
Levofloxacin—Urinary tract disorder—Epirubicin—uterine cancer	8.18e-05	0.000302	CcSEcCtD
Levofloxacin—Oedema peripheral—Epirubicin—uterine cancer	8.16e-05	0.000301	CcSEcCtD
Levofloxacin—Haematuria—Doxorubicin—uterine cancer	8.14e-05	0.000301	CcSEcCtD
Levofloxacin—Connective tissue disorder—Epirubicin—uterine cancer	8.14e-05	0.000301	CcSEcCtD
Levofloxacin—Urethral disorder—Epirubicin—uterine cancer	8.12e-05	0.0003	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Doxorubicin—uterine cancer	8.07e-05	0.000298	CcSEcCtD
Levofloxacin—Epistaxis—Doxorubicin—uterine cancer	8.05e-05	0.000297	CcSEcCtD
Levofloxacin—Sinusitis—Doxorubicin—uterine cancer	8.01e-05	0.000296	CcSEcCtD
Levofloxacin—Visual impairment—Epirubicin—uterine cancer	7.98e-05	0.000295	CcSEcCtD
Levofloxacin—Agranulocytosis—Doxorubicin—uterine cancer	7.96e-05	0.000294	CcSEcCtD
Levofloxacin—Erythema multiforme—Epirubicin—uterine cancer	7.83e-05	0.000289	CcSEcCtD
Levofloxacin—Bradycardia—Doxorubicin—uterine cancer	7.8e-05	0.000288	CcSEcCtD
Levofloxacin—Eye disorder—Epirubicin—uterine cancer	7.74e-05	0.000286	CcSEcCtD
Levofloxacin—Hypersensitivity—Etoposide—uterine cancer	7.73e-05	0.000286	CcSEcCtD
Levofloxacin—Tinnitus—Epirubicin—uterine cancer	7.72e-05	0.000285	CcSEcCtD
Levofloxacin—Haemoglobin—Doxorubicin—uterine cancer	7.7e-05	0.000285	CcSEcCtD
Levofloxacin—Flushing—Epirubicin—uterine cancer	7.68e-05	0.000284	CcSEcCtD
Levofloxacin—Cardiac disorder—Epirubicin—uterine cancer	7.68e-05	0.000284	CcSEcCtD
Levofloxacin—Rhinitis—Doxorubicin—uterine cancer	7.68e-05	0.000284	CcSEcCtD
Levofloxacin—Haemorrhage—Doxorubicin—uterine cancer	7.66e-05	0.000283	CcSEcCtD
Levofloxacin—Hepatitis—Doxorubicin—uterine cancer	7.66e-05	0.000283	CcSEcCtD
Levofloxacin—Hypoaesthesia—Doxorubicin—uterine cancer	7.62e-05	0.000282	CcSEcCtD
Levofloxacin—Pharyngitis—Doxorubicin—uterine cancer	7.6e-05	0.000281	CcSEcCtD
Levofloxacin—Urinary tract disorder—Doxorubicin—uterine cancer	7.57e-05	0.00028	CcSEcCtD
Levofloxacin—Oedema peripheral—Doxorubicin—uterine cancer	7.55e-05	0.000279	CcSEcCtD
Levofloxacin—Asthenia—Etoposide—uterine cancer	7.53e-05	0.000278	CcSEcCtD
Levofloxacin—Connective tissue disorder—Doxorubicin—uterine cancer	7.53e-05	0.000278	CcSEcCtD
Levofloxacin—Angiopathy—Epirubicin—uterine cancer	7.51e-05	0.000278	CcSEcCtD
Levofloxacin—Urethral disorder—Doxorubicin—uterine cancer	7.51e-05	0.000278	CcSEcCtD
Levofloxacin—Immune system disorder—Epirubicin—uterine cancer	7.48e-05	0.000276	CcSEcCtD
Levofloxacin—Mediastinal disorder—Epirubicin—uterine cancer	7.46e-05	0.000276	CcSEcCtD
Levofloxacin—Chills—Epirubicin—uterine cancer	7.43e-05	0.000275	CcSEcCtD
Levofloxacin—Pruritus—Etoposide—uterine cancer	7.42e-05	0.000274	CcSEcCtD
Levofloxacin—Arrhythmia—Epirubicin—uterine cancer	7.4e-05	0.000273	CcSEcCtD
Levofloxacin—Visual impairment—Doxorubicin—uterine cancer	7.38e-05	0.000273	CcSEcCtD
Levofloxacin—Alopecia—Epirubicin—uterine cancer	7.32e-05	0.00027	CcSEcCtD
Levofloxacin—Mental disorder—Epirubicin—uterine cancer	7.25e-05	0.000268	CcSEcCtD
Levofloxacin—Erythema multiforme—Doxorubicin—uterine cancer	7.24e-05	0.000268	CcSEcCtD
Levofloxacin—Erythema—Epirubicin—uterine cancer	7.21e-05	0.000266	CcSEcCtD
Levofloxacin—Malnutrition—Epirubicin—uterine cancer	7.21e-05	0.000266	CcSEcCtD
Levofloxacin—Diarrhoea—Etoposide—uterine cancer	7.18e-05	0.000265	CcSEcCtD
Levofloxacin—Eye disorder—Doxorubicin—uterine cancer	7.16e-05	0.000265	CcSEcCtD
Levofloxacin—Tinnitus—Doxorubicin—uterine cancer	7.14e-05	0.000264	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—uterine cancer	7.11e-05	0.000263	CcSEcCtD
Levofloxacin—Cardiac disorder—Doxorubicin—uterine cancer	7.11e-05	0.000263	CcSEcCtD
Levofloxacin—Flatulence—Epirubicin—uterine cancer	7.1e-05	0.000262	CcSEcCtD
Levofloxacin—Tension—Epirubicin—uterine cancer	7.07e-05	0.000261	CcSEcCtD
Levofloxacin—Dysgeusia—Epirubicin—uterine cancer	7.06e-05	0.000261	CcSEcCtD
Levofloxacin—Nervousness—Epirubicin—uterine cancer	7e-05	0.000259	CcSEcCtD
Levofloxacin—Back pain—Epirubicin—uterine cancer	6.97e-05	0.000258	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—uterine cancer	6.95e-05	0.000257	CcSEcCtD
Levofloxacin—Dizziness—Etoposide—uterine cancer	6.94e-05	0.000256	CcSEcCtD
Levofloxacin—Muscle spasms—Epirubicin—uterine cancer	6.93e-05	0.000256	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—uterine cancer	6.92e-05	0.000256	CcSEcCtD
Levofloxacin—Mediastinal disorder—Doxorubicin—uterine cancer	6.9e-05	0.000255	CcSEcCtD
Levofloxacin—Chills—Doxorubicin—uterine cancer	6.87e-05	0.000254	CcSEcCtD
Levofloxacin—Arrhythmia—Doxorubicin—uterine cancer	6.84e-05	0.000253	CcSEcCtD
Levofloxacin—Vision blurred—Epirubicin—uterine cancer	6.79e-05	0.000251	CcSEcCtD
Levofloxacin—Alopecia—Doxorubicin—uterine cancer	6.77e-05	0.00025	CcSEcCtD
Levofloxacin—Mental disorder—Doxorubicin—uterine cancer	6.71e-05	0.000248	CcSEcCtD
Levofloxacin—Ill-defined disorder—Epirubicin—uterine cancer	6.69e-05	0.000247	CcSEcCtD
Levofloxacin—Vomiting—Etoposide—uterine cancer	6.67e-05	0.000247	CcSEcCtD
Levofloxacin—Erythema—Doxorubicin—uterine cancer	6.67e-05	0.000246	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—uterine cancer	6.67e-05	0.000246	CcSEcCtD
Levofloxacin—Anaemia—Epirubicin—uterine cancer	6.66e-05	0.000246	CcSEcCtD
Levofloxacin—Agitation—Epirubicin—uterine cancer	6.62e-05	0.000245	CcSEcCtD
Levofloxacin—Rash—Etoposide—uterine cancer	6.62e-05	0.000245	CcSEcCtD
Levofloxacin—Dermatitis—Etoposide—uterine cancer	6.61e-05	0.000244	CcSEcCtD
Levofloxacin—Headache—Etoposide—uterine cancer	6.57e-05	0.000243	CcSEcCtD
Levofloxacin—Flatulence—Doxorubicin—uterine cancer	6.57e-05	0.000243	CcSEcCtD
Levofloxacin—Tension—Doxorubicin—uterine cancer	6.54e-05	0.000242	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—uterine cancer	6.53e-05	0.000241	CcSEcCtD
Levofloxacin—Malaise—Epirubicin—uterine cancer	6.5e-05	0.00024	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—uterine cancer	6.48e-05	0.000239	CcSEcCtD
Levofloxacin—Vertigo—Epirubicin—uterine cancer	6.48e-05	0.000239	CcSEcCtD
Levofloxacin—Syncope—Epirubicin—uterine cancer	6.46e-05	0.000239	CcSEcCtD
Levofloxacin—Leukopenia—Epirubicin—uterine cancer	6.45e-05	0.000238	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—uterine cancer	6.45e-05	0.000238	CcSEcCtD
Levofloxacin—Muscle spasms—Doxorubicin—uterine cancer	6.41e-05	0.000237	CcSEcCtD
Levofloxacin—Palpitations—Epirubicin—uterine cancer	6.37e-05	0.000235	CcSEcCtD
Levofloxacin—Loss of consciousness—Epirubicin—uterine cancer	6.34e-05	0.000234	CcSEcCtD
Levofloxacin—Cough—Epirubicin—uterine cancer	6.29e-05	0.000232	CcSEcCtD
Levofloxacin—Vision blurred—Doxorubicin—uterine cancer	6.29e-05	0.000232	CcSEcCtD
Levofloxacin—Nausea—Etoposide—uterine cancer	6.23e-05	0.00023	CcSEcCtD
Levofloxacin—Hypertension—Epirubicin—uterine cancer	6.22e-05	0.00023	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—uterine cancer	6.19e-05	0.000229	CcSEcCtD
Levofloxacin—Anaemia—Doxorubicin—uterine cancer	6.16e-05	0.000228	CcSEcCtD
Levofloxacin—Chest pain—Epirubicin—uterine cancer	6.14e-05	0.000227	CcSEcCtD
Levofloxacin—Arthralgia—Epirubicin—uterine cancer	6.14e-05	0.000227	CcSEcCtD
Levofloxacin—Myalgia—Epirubicin—uterine cancer	6.14e-05	0.000227	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—uterine cancer	6.13e-05	0.000226	CcSEcCtD
Levofloxacin—Anxiety—Epirubicin—uterine cancer	6.12e-05	0.000226	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.09e-05	0.000225	CcSEcCtD
Levofloxacin—Discomfort—Epirubicin—uterine cancer	6.06e-05	0.000224	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—uterine cancer	6.01e-05	0.000222	CcSEcCtD
Levofloxacin—Dry mouth—Epirubicin—uterine cancer	6e-05	0.000222	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—uterine cancer	5.99e-05	0.000221	CcSEcCtD
Levofloxacin—Syncope—Doxorubicin—uterine cancer	5.98e-05	0.000221	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—uterine cancer	5.97e-05	0.000221	CcSEcCtD
Levofloxacin—Confusional state—Epirubicin—uterine cancer	5.93e-05	0.000219	CcSEcCtD
Levofloxacin—Palpitations—Doxorubicin—uterine cancer	5.89e-05	0.000218	CcSEcCtD
Levofloxacin—Oedema—Epirubicin—uterine cancer	5.88e-05	0.000217	CcSEcCtD
Levofloxacin—Anaphylactic shock—Epirubicin—uterine cancer	5.88e-05	0.000217	CcSEcCtD
Levofloxacin—Loss of consciousness—Doxorubicin—uterine cancer	5.86e-05	0.000217	CcSEcCtD
Levofloxacin—Infection—Epirubicin—uterine cancer	5.84e-05	0.000216	CcSEcCtD
Levofloxacin—Cough—Doxorubicin—uterine cancer	5.82e-05	0.000215	CcSEcCtD
Levofloxacin—Shock—Epirubicin—uterine cancer	5.79e-05	0.000214	CcSEcCtD
Levofloxacin—Nervous system disorder—Epirubicin—uterine cancer	5.77e-05	0.000213	CcSEcCtD
Levofloxacin—Thrombocytopenia—Epirubicin—uterine cancer	5.76e-05	0.000213	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—uterine cancer	5.76e-05	0.000213	CcSEcCtD
Levofloxacin—Tachycardia—Epirubicin—uterine cancer	5.74e-05	0.000212	CcSEcCtD
Levofloxacin—Skin disorder—Epirubicin—uterine cancer	5.71e-05	0.000211	CcSEcCtD
Levofloxacin—Hyperhidrosis—Epirubicin—uterine cancer	5.69e-05	0.00021	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—uterine cancer	5.68e-05	0.00021	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—uterine cancer	5.68e-05	0.00021	CcSEcCtD
Levofloxacin—Myalgia—Doxorubicin—uterine cancer	5.68e-05	0.00021	CcSEcCtD
Levofloxacin—Anxiety—Doxorubicin—uterine cancer	5.66e-05	0.000209	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	5.64e-05	0.000208	CcSEcCtD
Levofloxacin—Discomfort—Doxorubicin—uterine cancer	5.61e-05	0.000207	CcSEcCtD
Levofloxacin—Anorexia—Epirubicin—uterine cancer	5.61e-05	0.000207	CcSEcCtD
Levofloxacin—Dry mouth—Doxorubicin—uterine cancer	5.55e-05	0.000205	CcSEcCtD
Levofloxacin—Hypotension—Epirubicin—uterine cancer	5.5e-05	0.000203	CcSEcCtD
Levofloxacin—Confusional state—Doxorubicin—uterine cancer	5.49e-05	0.000203	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—uterine cancer	5.44e-05	0.000201	CcSEcCtD
Levofloxacin—Anaphylactic shock—Doxorubicin—uterine cancer	5.44e-05	0.000201	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—uterine cancer	5.41e-05	0.0002	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Epirubicin—uterine cancer	5.36e-05	0.000198	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—uterine cancer	5.36e-05	0.000198	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—uterine cancer	5.34e-05	0.000197	CcSEcCtD
Levofloxacin—Thrombocytopenia—Doxorubicin—uterine cancer	5.33e-05	0.000197	CcSEcCtD
Levofloxacin—Insomnia—Epirubicin—uterine cancer	5.32e-05	0.000197	CcSEcCtD
Levofloxacin—Tachycardia—Doxorubicin—uterine cancer	5.31e-05	0.000196	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—uterine cancer	5.29e-05	0.000195	CcSEcCtD
Levofloxacin—Paraesthesia—Epirubicin—uterine cancer	5.28e-05	0.000195	CcSEcCtD
Levofloxacin—Hyperhidrosis—Doxorubicin—uterine cancer	5.26e-05	0.000194	CcSEcCtD
Levofloxacin—Dyspnoea—Epirubicin—uterine cancer	5.24e-05	0.000194	CcSEcCtD
Levofloxacin—Somnolence—Epirubicin—uterine cancer	5.23e-05	0.000193	CcSEcCtD
Levofloxacin—Anorexia—Doxorubicin—uterine cancer	5.19e-05	0.000192	CcSEcCtD
Levofloxacin—Dyspepsia—Epirubicin—uterine cancer	5.18e-05	0.000191	CcSEcCtD
Levofloxacin—Decreased appetite—Epirubicin—uterine cancer	5.11e-05	0.000189	CcSEcCtD
Levofloxacin—Hypotension—Doxorubicin—uterine cancer	5.09e-05	0.000188	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Epirubicin—uterine cancer	5.08e-05	0.000188	CcSEcCtD
Levofloxacin—Fatigue—Epirubicin—uterine cancer	5.07e-05	0.000187	CcSEcCtD
Levofloxacin—Pain—Epirubicin—uterine cancer	5.03e-05	0.000186	CcSEcCtD
Levofloxacin—Constipation—Epirubicin—uterine cancer	5.03e-05	0.000186	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	4.96e-05	0.000183	CcSEcCtD
Levofloxacin—Insomnia—Doxorubicin—uterine cancer	4.92e-05	0.000182	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—uterine cancer	4.89e-05	0.000181	CcSEcCtD
Levofloxacin—Dyspnoea—Doxorubicin—uterine cancer	4.85e-05	0.000179	CcSEcCtD
Levofloxacin—Feeling abnormal—Epirubicin—uterine cancer	4.85e-05	0.000179	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—uterine cancer	4.84e-05	0.000179	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Epirubicin—uterine cancer	4.81e-05	0.000178	CcSEcCtD
Levofloxacin—Dyspepsia—Doxorubicin—uterine cancer	4.79e-05	0.000177	CcSEcCtD
Levofloxacin—Decreased appetite—Doxorubicin—uterine cancer	4.73e-05	0.000175	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.7e-05	0.000174	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—uterine cancer	4.69e-05	0.000173	CcSEcCtD
Levofloxacin—Urticaria—Epirubicin—uterine cancer	4.67e-05	0.000173	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—uterine cancer	4.65e-05	0.000172	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—uterine cancer	4.65e-05	0.000172	CcSEcCtD
Levofloxacin—Abdominal pain—Epirubicin—uterine cancer	4.65e-05	0.000172	CcSEcCtD
Levofloxacin—Body temperature increased—Epirubicin—uterine cancer	4.65e-05	0.000172	CcSEcCtD
Levofloxacin—Feeling abnormal—Doxorubicin—uterine cancer	4.49e-05	0.000166	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Doxorubicin—uterine cancer	4.45e-05	0.000164	CcSEcCtD
Levofloxacin—Hypersensitivity—Epirubicin—uterine cancer	4.33e-05	0.00016	CcSEcCtD
Levofloxacin—Urticaria—Doxorubicin—uterine cancer	4.32e-05	0.00016	CcSEcCtD
Levofloxacin—Body temperature increased—Doxorubicin—uterine cancer	4.3e-05	0.000159	CcSEcCtD
Levofloxacin—Abdominal pain—Doxorubicin—uterine cancer	4.3e-05	0.000159	CcSEcCtD
Levofloxacin—Asthenia—Epirubicin—uterine cancer	4.22e-05	0.000156	CcSEcCtD
Levofloxacin—Pruritus—Epirubicin—uterine cancer	4.16e-05	0.000154	CcSEcCtD
Levofloxacin—Diarrhoea—Epirubicin—uterine cancer	4.02e-05	0.000149	CcSEcCtD
Levofloxacin—Hypersensitivity—Doxorubicin—uterine cancer	4.01e-05	0.000148	CcSEcCtD
Levofloxacin—Asthenia—Doxorubicin—uterine cancer	3.91e-05	0.000144	CcSEcCtD
Levofloxacin—Dizziness—Epirubicin—uterine cancer	3.89e-05	0.000144	CcSEcCtD
Levofloxacin—Pruritus—Doxorubicin—uterine cancer	3.85e-05	0.000142	CcSEcCtD
Levofloxacin—Vomiting—Epirubicin—uterine cancer	3.74e-05	0.000138	CcSEcCtD
Levofloxacin—Diarrhoea—Doxorubicin—uterine cancer	3.72e-05	0.000138	CcSEcCtD
Levofloxacin—Rash—Epirubicin—uterine cancer	3.71e-05	0.000137	CcSEcCtD
Levofloxacin—Dermatitis—Epirubicin—uterine cancer	3.71e-05	0.000137	CcSEcCtD
Levofloxacin—Headache—Epirubicin—uterine cancer	3.69e-05	0.000136	CcSEcCtD
Levofloxacin—Dizziness—Doxorubicin—uterine cancer	3.6e-05	0.000133	CcSEcCtD
Levofloxacin—Nausea—Epirubicin—uterine cancer	3.49e-05	0.000129	CcSEcCtD
Levofloxacin—Vomiting—Doxorubicin—uterine cancer	3.46e-05	0.000128	CcSEcCtD
Levofloxacin—Rash—Doxorubicin—uterine cancer	3.43e-05	0.000127	CcSEcCtD
Levofloxacin—Dermatitis—Doxorubicin—uterine cancer	3.43e-05	0.000127	CcSEcCtD
Levofloxacin—Headache—Doxorubicin—uterine cancer	3.41e-05	0.000126	CcSEcCtD
Levofloxacin—Nausea—Doxorubicin—uterine cancer	3.23e-05	0.000119	CcSEcCtD
